Citation Impact
Citing Papers
Attention‐Deficit‐Hyperactivity Disorder: An Update
2009
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder
2012
Psychiatric Pharmacogenomics in Pediatric Psychopharmacology
2012
National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007
2010
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Osteoarthritis
2019 Standout
Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis
2019
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Pharmacology of Penile Erection
2001
A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
2006
Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials
2015
Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
2014
Biomedical Importance of Indoles
2013 Standout
Industry sponsorship and research outcome
2017 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Dustin Ruff being referenced
A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
2007
Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials
2013
CYP2D6 and Clinical Response to Atomoxetine in Children and Adolescents With ADHD
2007
Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response
2008
Changes in Symptoms and Adverse Events After Discontinuation of Atomoxetine in Children and Adults With Attention Deficit/Hyperactivity Disorder
2004
High-Dose Atomoxetine Treatment of ADHD in Youths With Limited Response to Standard Doses
2007
Low-Dose Atomoxetine for Maintenance Treatment of Attention-Deficit/Hyperactivity Disorder
2006
Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder
2005
EFFICACY OF APOMORPHINE SL VS PLACEBO FOR ERECTILE DYSFUNCTION IN PATIENTS WITH HYPERTENSION
1999